|
|
|
Abstract Objective: To explore the clinical effects and safety of short-acting oral contraceptive (Yasmin) use and medicated-γintrauterine device insertion after artificial abortion. Methods: A total of 292 healthy pregnant women who underwent artificial abortion were recruited and randomly divided into two groups (146 women in each group). Women in IUD group were inserted medicated-γintrauterine device. And those in Yasmin group were given one tablet of Yasmin on the operation day for 21-day cycle as well as five courses of treatment. Postoperative vaginal bleeding amount and duration, vaginal discharge, endometrial thickness, menstrual recovery time and adverse reactions of the two groups were evaluated. Results: The duration of vaginal bleeding of Yasmin group was (4.35±2.22) d, significantly lower than that in IUD group ［(5.87±2.30) d, t=5.7455, P< 0.05)］. The rate of normal vaginal discharge in Yasmin group was 95.2%, significantly higher than that in IUD group (78.1%, χ2=18.496, P<0.05). Endometrial thickness of Yasmin group was more than that of IUD group (t=18.125, P<0.05). And the menstrual recovery time of Yasmin group was shorter than that of IUD group (t=40.257, P＞0.05). Contraceptive failure rates of the two groups were 1.4% and 2.8% respectively, showing no statistically significant difference (χ2=0.681, P＞0.05). The incidence of adverse reactions one month after the operation in Yasmin group was significantly lower than that in IUD group (χ2=5508, P<0.05). Conclusion: Yasmin could be used as the preferred method after abortion, which significantly improves patient's postoperative situation, and helps the body function to recover, while IUD insertion could serve as a preferred way of long-term contraception.
|
|
|
|
|
|
|
|
